4-HYDROXYANDROSTENEDIONE (4-OHA) AS 3RD-LINE ENDOCRINE THERAPY IN POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER

Authors
GENNATAS CS PSYCHOGIOS J DARDOUFAS C TSAVARIS N ATHANASIADIS S
Citation
Cs. Gennatas et al., 4-HYDROXYANDROSTENEDIONE (4-OHA) AS 3RD-LINE ENDOCRINE THERAPY IN POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER, European journal of cancer, 33, 1997, pp. 702-702
Citations number
NO
Categorie Soggetti
Oncology
Journal title
European journal of cancer → ACNP
ISSN journal
09598049
Volume
33
Year of publication
1997
Supplement
8
Pages
702 - 702
Database
ISI
SICI code
0959-8049(1997)33:<702:4(A3ET>2.0.ZU;2-R